Currently, there are many treatments available for these retinopathies, mainly anti-vascular endothelial growth factor (anti-VEGF) agents for nAMD and anti-VEGF or corticosteroids for DME [14,15]. The gene discussed is VEGFA; the disease is retinal disorder.